Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
0.8700
-0.0378 (-4.16%)
At close: May 30, 2025, 4:00 PM
0.8708
+0.0008 (0.09%)
After-hours: May 30, 2025, 7:29 PM EDT
MBRX's stock price has decreased by -80.32% in the past year and price targets may not have had time to catch up.
Moleculin Biotech Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$6.00
Upside
+589.66%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $4 | Hold → Strong Buy | Upgrades | $4 | +359.77% | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +819.54% | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +819.54% | Mar 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 | Strong Buy | Maintains | $8 | +819.54% | Mar 3, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $20 → $8 | Strong Buy | Maintains | $20 → $8 | +819.54% | Nov 12, 2024 |
| Roth MKM | Roth MKM | Strong Buy Maintains $40 | Strong Buy | Maintains | $40 | +4,497.70% | Apr 12, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $45 → $20 | Strong Buy | Maintains | $45 → $20 | +2,198.85% | Mar 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +5,072.41% | Dec 14, 2023 |
| Roth MKM | Roth MKM | Strong Buy Maintains $240 | Strong Buy | Maintains | $240 | +27,486.21% | Apr 18, 2023 |
| Oppenheimer | Oppenheimer | Buy Reiterates $75 | Buy | Reiterates | $75 | +8,520.69% | Mar 24, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $30 → $210 | Buy | Initiates | $30 → $210 | +24,037.93% | Jul 18, 2022 |